Pancreatic Cancer Research

ResearcherMedical University of GrazNo recent work listed

Harald Mangge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4067-247X; OpenAlex author ID A5054772233. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Co-author DOI 10.3390/ma16072906↗
  2. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/0929867324666170510150124↗
  3. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. First author DOI 10.1007/s13402-016-0275-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefan Lyer · 2 shared papers, 2017–2023 · strength 0.27
  2. Hai Yang · 1 shared paper, 2023 · strength 0.18
  3. Jonas Dinter · 1 shared paper, 2023 · strength 0.18
  4. Christian P. Pilarsky · 1 shared paper, 2023 · strength 0.18
  5. Johannes Haybaeck · 2 shared papers, 2016–2017 · strength 0.18
  6. Valentin Taucher · 1 shared paper, 2016 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.